| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 10/27/1994 | CA2094843A1 Use of disulfiram to prevent neurologic and cardiovascular damage |
| 10/26/1994 | EP0621031A2 Ointment for wound treatment |
| 10/26/1994 | EP0620741A1 Cytotoxic drug therapy |
| 10/26/1994 | EP0620739A1 Method of treating tnf-dependent inflammation using tumor necrosis factor antagonists |
| 10/26/1994 | EP0527835B1 Dosage form to deliver an antiparkinson agent |
| 10/26/1994 | EP0192667B1 Device for initiating reperfusion treatment when heart attack symptoms are present |
| 10/26/1994 | CN1026319C Pharmaceutical compositions |
| 10/25/1994 | US5358502 PH-triggered osmotic bursting delivery devices |
| 10/25/1994 | CA1332713C Skin penetration enhancement using free base and acid addition salt combinations of active agents |
| 10/19/1994 | EP0620001A1 Aqueous pharmaceutical suspension and process for preparation thereof |
| 10/19/1994 | EP0619741A1 Polar lipid composition of plant origin |
| 10/19/1994 | EP0619739A1 Composition for irrigating intraocular tissues and maintaining mydriasis during intraocular surgery |
| 10/19/1994 | EP0577760A4 Sequential dosing of antifungal and antiinflammatory compositions. |
| 10/18/1994 | US5356892 Administering anticholinergic muscarinic antagonist to control abnormal postnatal growth of eye of animal |
| 10/17/1994 | CA2094203A1 Inhibition of angiogenesis |
| 10/13/1994 | WO1994023068A1 Method for screening for receptor agonists |
| 10/13/1994 | WO1994022869A1 FURO[3,2-b]PYRIDINES AND THIENO[3,2-b]PYRIDINES AS INHIBITORS OF LEUKOTRIENE BIOSYNTHESIS |
| 10/13/1994 | WO1994022490A1 Conjugates of proteins and bifunctional ligands |
| 10/13/1994 | WO1994022483A2 Prodrugs with enhanced penetration into cells |
| 10/13/1994 | WO1994022480A1 Hiv protease inhibitors in pharmaceutical combinations for the treatment of aids |
| 10/13/1994 | WO1994022455A1 Methods of affecting the growth of living tissue in mammals and compounds and compositions therefor |
| 10/13/1994 | WO1994022437A2 Method for treating amyloidosis |
| 10/13/1994 | WO1994022312A1 Method and composition for treatment of osteoporosis |
| 10/13/1994 | CA2160135A1 Method for screening for receptor agonists |
| 10/13/1994 | CA2159717A1 Methods of affecting the growth of living tissue in mammals and compounds and compositions therefor |
| 10/13/1994 | CA2156262A1 Furo¬3,2-b|pyridines and thieno¬3,2-b|pyridines as inhibitors of leukotriene biosynthesis |
| 10/11/1994 | US5354765 Synergistic |
| 10/11/1994 | CA1332353C Pharmaceutical composition for the treatment of skin wounds |
| 10/11/1994 | CA1332350C Combination of angiotensin converting enzyme inhibitors with potassium channel modulators and use thereof in pharmaceuticals |
| 10/06/1994 | DE4314976C1 Transdermal therapeutic systems for the administration of drugs, process for their production and their use |
| 10/05/1994 | EP0617968A1 HIV protease inhibitors in pharmaceutical combinant for the treatment of AIDS |
| 10/05/1994 | EP0617617A1 Compositions containing histamine-h2-receptor antagonists at low dosage |
| 10/05/1994 | EP0617615A1 Pharmaceutical composition and process for the preparation thereof |
| 10/04/1994 | US5352688 Methods for the treatment of bradyphrenia in parkinson's disease |
| 10/04/1994 | US5352683 Administering N-methyl-D-aspartate receptor antagonist |
| 10/04/1994 | US5352669 Increases host responsiveness to anti-neoplastic alkylating agents including chloroethylating agents for chemotheraputical treatment |
| 10/04/1994 | US5352666 Antiglaucoma compositions and methods |
| 10/04/1994 | CA1332224C Mixture of a substance having thrombolytic activity and of an antithrombotic substance |
| 10/01/1994 | CA2120192A1 Hiv protease inhibitors useful for the treatment of aids |
| 09/29/1994 | WO1994021792A2 Inhibition of selected tumor growth with recombinant viral vectors |
| 09/29/1994 | WO1994021288A1 Composition and method for reducing toxicity of biologically-active factors |
| 09/29/1994 | WO1994021286A1 Composition for oral administration of peptides |
| 09/29/1994 | WO1994021278A1 Potassium channel blocking compounds and their use |
| 09/29/1994 | WO1994021271A1 Methods and compositions for inducing phase separation of epithelial lipid bilayers |
| 09/29/1994 | WO1994021244A1 Method of treating addictive behaviors |
| 09/29/1994 | WO1994021241A1 New use of anti-acne agents |
| 09/29/1994 | WO1994021230A1 Method and compositions for disrupting the epithelial barrier function |
| 09/29/1994 | CA2158546A1 Inhibition of selected tumor growth with recombinant viral vectors |
| 09/29/1994 | CA2158051A1 Potassium channel blocking compounds and their use |
| 09/28/1994 | EP0617127A1 Antigenic epitopes on B cell-bound IgE Immunoglobulins |
| 09/28/1994 | EP0616806A1 Phenylenediamine or benzimidazole derivatives for treating coccidiosis |
| 09/28/1994 | EP0616536A1 INHIBITING TRANSFORMING GROWTH FACTOR $g(b) TO PREVENT ACCUMULATION OF EXTRACELLULAR MATRIX |
| 09/28/1994 | EP0616532A1 Use of peripheral-type benzodiazepine sites for treatment of cns trauma or disease |
| 09/28/1994 | EP0616524A1 Medicaments |
| 09/28/1994 | EP0616523A1 Medicaments |
| 09/28/1994 | EP0616493A1 Methods and compositions for reducing multi-drug resistance |
| 09/28/1994 | CN1092654A Use of hyaluronic acid and forms to prevent arterial restenosis |
| 09/27/1994 | US5350760 Aza-5,5-fused hetrocyclic acids as leukotriene antagonists |
| 09/27/1994 | US5350744 Antiinflammatory, antiallergen |
| 09/27/1994 | US5350578 Inhibition of arterial thrombotic occlusion or thromboembolism |
| 09/27/1994 | CA2119820A1 Anticoccidial methods and feedstuffs |
| 09/27/1994 | CA1332150C Pharmaceutical compositions comprising cyclosporins |
| 09/21/1994 | EP0615749A2 Use of NMDA antagonists for the treatment of pain |
| 09/21/1994 | CN1092321A Methods for preparing multidrug resistance in cancer cells |
| 09/20/1994 | US5348739 Combined anti-tumor therapy with interleukin-2 and histamine, analogs thereof or H2 -receptor agonists |
| 09/20/1994 | US5348729 Administering antagonists, measuring hormone level |
| 09/15/1994 | WO1994020133A1 Supplemented and unsupplemented tissue sealants, methods of their production and use |
| 09/15/1994 | WO1994020112A1 Reduction of boar odor in meat |
| 09/15/1994 | WO1994020093A1 Treatment of tumors with compounds having rxr retinoid receptor agonist activity |
| 09/15/1994 | WO1994020086A1 Pharmaceutical compositions comprising paracetamol and l-cysteine or a precursor thereof |
| 09/15/1994 | WO1994020083A1 Glycosylation of lipids and lipid-containing particles, and diagnostic and therapeutic methods and materials derived therefrom |
| 09/15/1994 | WO1994015598A3 Methods for the improvement of cognition with functional antagonists of the glycine nmda receptor complex |
| 09/15/1994 | WO1994015488A3 Rehydration drink |
| 09/15/1994 | WO1994004688A3 Cationic peptides and method for production |
| 09/15/1994 | CA2157865A1 Glycosylation of lipids and lipid-containing particles, and diagnostic and therapeutic methods and materials derived therefrom |
| 09/15/1994 | CA2157798A1 Treatment of tumors with compounds having rxr retinoid receptor agonist activity |
| 09/14/1994 | EP0614357A1 Immunopotentiatory agents |
| 09/13/1994 | US5346903 Aqueous suspension preparation for injection, method for producing the same and use thereof for producing pain relief |
| 09/13/1994 | US5346894 Treatment of lyso PAF-mediated diseases with PAF antagonists and procedure for determining their efficacy |
| 09/13/1994 | US5346891 Lipopolysaccharide-producing bacteria, lipopolysaccharides, and lipopolysaccharide-containing, medicines and veterinary medicines |
| 09/13/1994 | US5346696 Recombinent Interferon |
| 09/07/1994 | EP0613944A2 Methods for regulating the immune response using CTLA4-binding molecules and IL4-binding molecules |
| 09/07/1994 | EP0613371A1 New combination of formoterol and budesonide |
| 09/07/1994 | EP0563127B1 Improved treatment method for cancer |
| 09/07/1994 | EP0422068B1 Pharmacological treatment of ocular development |
| 09/07/1994 | CN1091613A Method for enhancing bioavailability of beta-carotene |
| 09/06/1994 | US5344832 Administering dopamine agonist and prolactin stimulator |
| 09/06/1994 | US5344774 Human intracisternal A-type retroviral particles associated with sjogren's syndrome |
| 09/01/1994 | WO1994018983A1 Hormone replacement therapy |
| 09/01/1994 | WO1994018981A1 Fibrinogen receptor antagonists |
| 09/01/1994 | WO1994018970A1 Cold/sinus preparation consisting of phenindamine tartarate with or without therapeutic agents |
| 09/01/1994 | WO1994018964A1 USE OF φ-GUANIDINOCARBOXYLIC ACID ESTERS |
| 09/01/1994 | WO1994018961A1 Cancer treatment |
| 09/01/1994 | WO1994018959A1 Calcium receptor-active molecules |
| 09/01/1994 | WO1994018958A1 5-ht2 receptor antagonist compositions useful in treating venous conditions |
| 09/01/1994 | WO1994012638A3 Interleukin-3 (il-3) multiple mutation polypeptides |
| 09/01/1994 | WO1994008474A3 Medical food and method of administration |
| 09/01/1994 | CA2155123A1 Fibrinogen receptor antagonists |
| 08/31/1994 | EP0612520A2 PH-triggered osmotic bursting delivery devices |
| 08/31/1994 | EP0612248A1 Combination chemotherapy |